$2.120
+0.144 (+6.80%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
LRMR Prediction & Forecast by Similar Chart Analysis
Alphio's LRMR stock price prediction model matches the current Larimar Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.15 (+1.23%). The 1-week path is $2.15 (+1.26%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Larimar Therapeutics Inc Stock?
Larimar Therapeutics Inc (LRMR) is a good buy right now at a current price of $1.985, especially considering the analyst price targets ranging from $10 to $14, which suggests significant upside potential. The company's lead product, nomlabofusp, is projected to launch commercially in 2027, with first-year sales estimates of $47.9 million and potential peak sales exceeding $1.1 billion by 2040. However, the main risk is the company's current negative net income, which was reported at -32.8 million in Q2 2026, indicating ongoing financial challenges.
LRMR stock price ended at $2.12 on Monday, after rising +6.80%
Larimar Therapeutics Inc (LRMR) last closed at $2.12, gaining +6.80%. These facts feed the 1-day and 1-week LRMR price prediction above.
Forecast Drivers
Larimar Therapeutics Inc (LRMR) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches LRMR, ranked by similarity.
Seasonality analysis for LRMR
Historically the probability of a positive October return for LRMR is 71.19%. September offers the highest probability of a positive month at 72.58%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for LRMR
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $3.35 | $3.67 | $3.90 | +73.35% |
| Nov 2026 | $3.18 | $3.40 | $3.79 | +60.44% |
| Dec 2026 | $2.89 | $2.91 | $3.13 | +37.05% |
In 2026, Larimar Therapeutics Inc (LRMR) is projected to range from $2.89 to $3.90.
Larimar Therapeutics Inc 2026 monthly forecast
In Oct 2026, Larimar Therapeutics Inc is projected to average $3.67, with a low of $3.35 and high of $3.90.
In Nov 2026, Larimar Therapeutics Inc is projected to average $3.40, with a low of $3.18 and high of $3.79.
In Dec 2026, Larimar Therapeutics Inc is projected to average $2.91, with a low of $2.89 and high of $3.13.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.